✦ LIBER ✦

P180 A cost effectiveness analysis of adjuvant chemotherapy for node positive early breast cancer in South Africa: docetaxel, doxorubicin and cyclophosphamide (TAC) versus 5-fluorouracil, doxorubicin and cyclophosphamide (FAC)

✍ Scribed by B.L. Rapoport; S.D. Moodley; C. Jacobs; R. Pienaar; S. Fourie; W.M. Szpak

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost–effectiveness analysis of adjuvant

✍ Sang Gyu Lee; Young Geon Jee; Hyun Chul Chung; Sung-Bae Kim; Jungsil Ro; Young-H 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 231 KB

PCN12 IMPACT OF ADJUVANT CHEMOTHERAPY WI

✍ H Miadi-Fargier; C Le Pen; MC Woronoff-Lemsi; JP Guastalla; X Pivot; H Roché; F 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

Improvement in Disease-Free Survival wit

✍ Amy I. D'Orazio; Joyce O'Shaughnessy 📂 Article 📅 2002 🏛 CIG Media Group, LP. 🌐 English ⚖ 96 KB

Cost-effectiveness analysis of adjuvant

✍ Heather-Jane Au; Kamran Golmohammadi; Tallal Younis; Shailendra Verma; Stephen C 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 307 KB

Quality of life and toxicity in breast c

✍ N. Hatam; N. Ahmadloo; A. Ahmad Kia Daliri; P. Bastani; M. Askarian 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 178 KB

CN3 COMPARISON OFTHE COST-EFFECTIVENESS

✍ N Mittmann; M Koo; K Alloul; M Trudeau 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB